The Alzheimer’s Association is calling participation in registries an “unnecessary barrier” for access to anti-amyloid drugs for Alzheimer’s disease after CMS announced it will immediately cover anti-amyloid drugs for early stages of Alzheimer’s if they receive full, traditional approval from FDA, but is holding firm that all patients receiving the drugs participate in a registry detailing the treatment’s effectiveness. In a statement released Thursday (June 1) , CMS Administrator Chiquita Brooks-LaSure says the class of drugs that aim to slow...

Mark Cuban’s online generic drug pharmacy could soon manufacture injectable drugs currently in shortage, but the company will likely run into the same market issues that are, in part, fueling the recent drug shortage spike in the United States, one expert told Inside Health Policy . FDA currently lists more than 130 ongoing shortages in its drug shortage database, ranging from common antibiotics to critical cancer medications. The agency and lawmakers say low generic drug prices are contributing to the...